210 related articles for article (PubMed ID: 28477546)
1. Prevalence and treatment of psychiatric disorders other than psychosis in children and adolescents with 22q11DS: Examining associations with social and role functioning.
Armando M; Lin A; Pontillo M; Vicari S
Psychiatry Res; 2017 Aug; 254():238-243. PubMed ID: 28477546
[TBL] [Abstract][Full Text] [Related]
2. Autism Spectrum and psychosis risk in the 22q11.2 deletion syndrome. Findings from a prospective longitudinal study.
Fiksinski AM; Breetvelt EJ; Duijff SN; Bassett AS; Kahn RS; Vorstman JAS
Schizophr Res; 2017 Oct; 188():59-62. PubMed ID: 28119035
[TBL] [Abstract][Full Text] [Related]
3. Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning.
Armando M; Girardi P; Vicari S; Menghini D; Digilio MC; Pontillo M; Saba R; Mazzone L; Lin A; Klier CM; Schäfer MR; Amminger GP
Schizophr Res; 2012 Aug; 139(1-3):151-6. PubMed ID: 22627123
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome.
Hooper SR; Curtiss K; Schoch K; Keshavan MS; Allen A; Shashi V
Res Dev Disabil; 2013 May; 34(5):1758-69. PubMed ID: 23506790
[TBL] [Abstract][Full Text] [Related]
5. Impact of psychiatric comorbidity and cognitive deficit on function in 22q11.2 deletion syndrome.
Yi JJ; Calkins ME; Tang SX; Kohler CG; McDonald-McGinn DM; Zackai EH; Savitt AP; Bilker WB; Whinna DA; Souders MC; Emanuel BS; Gur RC; Gur RE
J Clin Psychiatry; 2015 Oct; 76(10):e1262-70. PubMed ID: 26528648
[TBL] [Abstract][Full Text] [Related]
6. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
[TBL] [Abstract][Full Text] [Related]
7. Trajectories of psychiatric diagnoses and medication usage in youth with 22q11.2 deletion syndrome: a 9-year longitudinal study.
Kates WR; Mariano MA; Antshel KM; Chandra S; Gamble H; Giordano M; MacMaster E; Mattar M; St Fleur D; Faraone SV; Fremont WP
Psychol Med; 2019 Aug; 49(11):1914-1922. PubMed ID: 30226117
[TBL] [Abstract][Full Text] [Related]
8. Glutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome.
Evers LJ; van Amelsvoort TA; Bakker JA; de Koning M; Drukker M; Curfs LM
Psychopharmacology (Berl); 2015 Sep; 232(18):3319-25. PubMed ID: 26055684
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated.
Tang SX; Yi JJ; Calkins ME; Whinna DA; Kohler CG; Souders MC; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
Psychol Med; 2014 Apr; 44(6):1267-77. PubMed ID: 24016317
[TBL] [Abstract][Full Text] [Related]
10. The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.
Tang SX; Moore TM; Calkins ME; Yi JJ; Savitt A; Kohler CG; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Gur RC; Gur RE
Biol Psychiatry; 2017 Jul; 82(1):17-25. PubMed ID: 27832840
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive profile in psychotic versus nonpsychotic individuals with 22q11.2 deletion syndrome.
Weinberger R; Yi J; Calkins M; Guri Y; McDonald-McGinn DM; Emanuel BS; Zackai EH; Ruparel K; Carmel M; Michaelovsky E; Weizman A; Gur RC; Gur RE; Gothelf D
Eur Neuropsychopharmacol; 2016 Oct; 26(10):1610-8. PubMed ID: 27524298
[TBL] [Abstract][Full Text] [Related]
12. Contribution of congenital heart disease to neuropsychiatric outcome in school-age children with 22q11.2 deletion syndrome.
Yi JJ; Tang SX; McDonald-McGinn DM; Calkins ME; Whinna DA; Souders MC; Zackai EH; Goldmuntz E; Gaynor JW; Gur RC; Emanuel BS; Gur RE
Am J Med Genet B Neuropsychiatr Genet; 2014 Mar; 165B(2):137-47. PubMed ID: 24265253
[TBL] [Abstract][Full Text] [Related]
13. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome.
Vorstman JA; Breetvelt EJ; Duijff SN; Eliez S; Schneider M; Jalbrzikowski M; Armando M; Vicari S; Shashi V; Hooper SR; Chow EW; Fung WL; Butcher NJ; Young DA; McDonald-McGinn DM; Vogels A; van Amelsvoort T; Gothelf D; Weinberger R; Weizman A; Klaassen PW; Koops S; Kates WR; Antshel KM; Simon TJ; Ousley OY; Swillen A; Gur RE; Bearden CE; Kahn RS; Bassett AS;
JAMA Psychiatry; 2015 Apr; 72(4):377-85. PubMed ID: 25715178
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive profile and onset of psychosis symptoms in children, adolescents and young adults with 22q11 deletion syndrome: A longitudinal study.
Pontillo M; Menghini D; Vicari S
Schizophr Res; 2019 Jun; 208():76-81. PubMed ID: 31056275
[TBL] [Abstract][Full Text] [Related]
15. All that glitters is not gold: prevalence and relevance of psychotic-like experiences in clinical sample of children and adolescents aged 8-17 years old.
Pontillo M; De Luca M; Pucciarini ML; Vicari S; Armando M
Early Interv Psychiatry; 2018 Aug; 12(4):702-707. PubMed ID: 27578268
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal study of premorbid adjustment in 22q11.2 deletion (velocardiofacial) syndrome and association with psychosis.
Radoeva PD; Fremont W; Antshel KM; Kates WR
Dev Psychopathol; 2017 Feb; 29(1):93-106. PubMed ID: 26864886
[TBL] [Abstract][Full Text] [Related]
17. Cognitive phenotype and psychiatric disorder in 22q11.2 deletion syndrome: A review.
Biswas AB; Furniss F
Res Dev Disabil; 2016; 53-54():242-57. PubMed ID: 26942704
[TBL] [Abstract][Full Text] [Related]
18. Musical auditory processing, cognition, and psychopathology in 22q11.2 deletion syndrome.
Gao L; Tang SX; Yi JJ; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Calkins ME; Gur RE
Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):765-773. PubMed ID: 30444066
[TBL] [Abstract][Full Text] [Related]
19. The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms.
Vorstman JAS; Morcus MEJ; Duijff SN; Klaassen PWJ; Heineman-de Boer JA; Beemer FA; Swaab H; Kahn RS; van Engeland H
J Am Acad Child Adolesc Psychiatry; 2006 Sep; 45(9):1104-1113. PubMed ID: 16926618
[TBL] [Abstract][Full Text] [Related]
20. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
